Assessing the Impact of the Center for Medicare and Medicaid Services Policy Guidance on Part D Prescriptions Among Hospice Patients

Abstract

Hospice care facilities are required to provide prescription drugs related to a hospice patient’s terminal illness. From October 2010 to present, the Center for Medicare and Medicaid Services (CMS) has issued a series of communications regarding Medicare paying for hospice patients’ prescription drugs under Part D that should be covered under the hospice Medicare Part A benefit. On April 4, 2011, CMS issued specific policy guidance to providers aimed at preventing inappropriate billing. While CMS has documented Part D prescription decreases in hospice patients, no research exists that connects these decreases and the policy guidance. This study aims to evaluate the effect of the April 4, 2011, policy guidance on hospice patients’ Part D prescriptions. This study employed generalized estimating equations to assess (1) total monthly average prescriptions of all medications and (2) four categories of commonly prescribed hospice medications in pre-and-post policy guidance. This research used the Medicare claims of 113,260 Part D-enrolled Medicare male patients aged 66 and older between April 2009 and March 2013, including 110,547 non-hospice patients and 2713 hospice patients. Hospice patients’ monthly average total Part D prescriptions decreased from 7.3 pre-policy guidance to 6.5 medications following the issuing of the guidance, while the four categories of hospice-specific medications decreased from .57 to .49. The findings of this study show that CMS’s guidance issued to providers to prevent the inappropriate billing of hospice patients’ prescriptions to the Part D benefit may lead to Part D prescription decreases as observed in this sample.

Keywords

Hospice policies prescription medicare waste

Get full access to this article

View all access options for this article.

References

Davis

. Medicare hospice benefit: Early program experiences. Health Care Financ. 1988;9(4):99-111.

Harrison

Connor

. First Medicare demonstration of concurrent provision of curative and hospice services for end-of-life care. Am J Publ Health. 2016;106(8):1405-1408.

Centers for Medicare and Medicaid Services . 42 CFR Part 418 Medicare and Medicaid Programs: Hospice Conditions of Participation; Final Rule. Washington, D.C.: US Department of Health and Human Services; 1983.

Bill summary of the tax equity and fiscal responsibility Act of 1982. §§ 401-407;96, Pub. L. No. 97-248.

Centers for Medicare and Medicaid Services . Medicare Hospice Benefits. Washington, D.C: U.S. Department of Health and Human Services; February; 2019.

Part D/prescription drug benefits. Center for Medicare Advocacy. Web site. https://www.medicareadvocacy.org/medicare-info/medicare-part-d/#introduction Published 2020. Accessed March 3 2020.

Zhang

Donohue

Lave

O'Donnell

Newhouse

. The effect of medicare Part D on drug and medical spending. N Engl J Med. 2009;361(1):52-61.

Prescription drug coverage (parts A, B, and D). Medicare Rights Center. Web site. https://www.medicareinteractive.org/get-answers/medicare-covered-services/medicare-coverage-overview/prescription-drug-coverage-parts-a-b-and-d Published 2020. Accessed March 2020.

Centers for Medicare and Medicaid Services . Hospice Toolkit: Program Integrity-An Overview for Medicaid Hospice Providers. Washington, D.C.: U.S. Department of Health and Human Services; 2016.

10.

Centers for Medicare and Medicaid Services . Chapter 9—Part D Program to Control Fraud, Waste, and Abuse of the Prescription Drug Benefit Manual. Washington, D.C.: U.S. Department of Health and Human Services; 2013.

11.

Centers for Medicare and Medicaid Services . FY 2022 hospice wage index and payment rate update, hospice conditions of participation updates, hospice and home Health quality reporting program requirements; proposed rule. 42 CFR Part 418 and 484. CMS-1754-P. U.S. Department of Health and human services. April 2021;14:19700-19774.

12.

Tudor

CG.

Preventing Part D Payment for Hospice Drugs. Washington, D.C.: Center for Medicare and Medicaid Services; October 22, 2010.

13.

Center for Medicare and Medicaid Services . Announcement of calendar year (CY) 2012 Medicare advantage capitation rates and Medicare advantage and Part D payment policies and final call letter. U.S. Departments of Health and Human Services. April 4, 2011.

14.

Tudor

Wilson

MajesticPart

M.D

. payment for drugs for beneficiaries enrolled in hospice-request for comment. Center for Medicare and Medicaid Services. December 6. Washington, D.C: U.S. Department of Health and human services; 2013.

15.

McCutcheon

Wilson

. Part D payment for drugs for beneficiaries enrolled in hospice-final 2014. Center for Medicare and Medicaid Services March 2014;10:1-17.

16.

Larrick

WilsonPart

L.D

Payment for Drugs for Beneficiaries Enrolled in Medicare Hospice. Washington, D.C.: Center for Medicare and Medicaid Services. July 18, 2014.

17.

Chavez-Valdez

Wilson

. Update on Part D payment responsibility for drugs for beneficiaries enrolled in Medicare hospice. Center for Medicare and Medicaid Services. 2016 November 15; U.S. Department of health and human services: Washington, D.C.

18.

Chavez-Valdez AL Part D drug management program policy guidance. Center for Medicare and Medicaid Services. November 20, 2018;U.S. Department of health and human services: Washington, D.C.

19.

Levinson

. Medicare Could Be Paying Twice for Prescription Drugs for Beneficiaries in Hospice 2012 (OIG Report A‐06–10–00059) (Online). Washington, D.C.: U.S. Department of Health and Human Services; 2017.

20.

Levinson

. Hospices Inappropriately Billed Medicare over $250 Million for General Inpatient Care (OIG Report A‐02-10-00491)(online). Washington, D.C.: U.S. Department of Health and Human Services; 2016.

21.

Chiedi

. Medicare Part D Is Still Paying Millions for Drugs Already Paid for under the Part A Hospice Benefit (OIG Report A‐06-17-08004)(online). Washington, D.C.: U.S. Department of Health and Human Services; 2019.

22.

National Cancer Institute SEER-Medicare : Brief description of the SEER-medicare database. Web site. https://healthcaredelivery.cancer.gov/seermedicare/overview/ Published May 16, 2019. Accessed March 28, 2020.

23.

Centers for Medicare and Medicaid Services . 42 CFR Part 418 Medicare and Medicaid Programs: Hospice Conditions of Participation; Final Rule. Washington, D.C.: U.S. Department of Health and Human Services; 2008.

24.

Stata

. v14.0. College Station, TX, USA: Stata Corp; 2020.